Please assess the completion status of the following clinical trial:

Trial Title: Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~All subjects are eligible except for the following special cases:~Exclusion Criteria:~* Female subjects who are or may be pregnant will NOT be eligible.~* The minimum age for all subjects is 18 years old. No subjects under the age of 18 shall be considered.~* If subject has received an imaging contrast agent of any kind within the past 7 days, they shall not be included in the study.~* Subjects for whom MRI is contraindicated as set forth by the City of Hope Department of Radiology. These include:~  * electrical implants such as cardiac pacemakers or perfusion pumps~ * ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants~ * ferromagnetic objects such as jewelry or metal clips in clothing~ * pre-existing medical conditions, including a likelihood of developing seizures or anxiety disorders such as claustrophobia, panic attacks or any psychiatric disorder~ * any greater than normal potential for cardiac arrest~ * any subject with known kidney insufficiency function as evidenced by an abnormal serum creatinine (normal = 0.6 - 1.5 mg/dL) from a blood test performed on the subject within the past 6 months of the study date.~ * Any subject with abnormal creatinine clearance (normal = 100-130 ml/min/1.73m2), as measured by a direct test or from plasma creatinine (14) levels shall be excluded.~* Normal subjects with a history of severe claustrophobia will not be eligible.~* For ease of recruiting and study management purposes, only subjects who can give consent in English shall be eligible for this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: t

Study Arms:
- DCE-MRI (dynamic contrast-enhanced MRI) (Type: None): Patients undergo DCE-MRI over approximately 30-60 minutes consisting of an anatomical scout image to localize the region of interest, a set of pre-injection scans to calibrate the dynamic image set, a dynamic image set during which contrast agent will be injected, and a set of post-injection scans to calibrate the DCE-MRI database.

Based on this trial design, predict the completion outcome and termination type (if applicable).